(NASDAQ: AVR) Anteris Technologies Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 31.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.65%.
Anteris Technologies Global's earnings in 2025 is N/A.On average, 2 Wall Street analysts forecast AVR's earnings for 2025 to be -$71,943,864, with the lowest AVR earnings forecast at -$73,206,037, and the highest AVR earnings forecast at -$70,681,691.
In 2026, AVR is forecast to generate -$61,485,858 in earnings, with the lowest earnings forecast at -$65,632,998 and the highest earnings forecast at -$57,338,718.